Oxazolidinones possess potent antibacterial activity against Gram-positive bacteria pathogens such as methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci and Mycobacterium tuberculosis. Discovery and development of novel oxazolidinone derivatives with improved antibacterial activity and less side-effects can be attained by extensive structural modifications around the phenyl-oxazolidinone moiety. Thus, a new oxazolidinone derivative containing 5-nitrofuran-2-carbonyl-glycinyl moiety (PH 189) was synthesized in our lab and shown to have potent in vitro antibacterial activity against Gram-positive pathogenic bacterial strains, and there are plans to investigate the in vivo efficacy in a Mycobacterium tuberculosis mouse infected model. In this regard, there is a need to develop analytical methods for stability study and quantitation of PH-189. Therefore, the aims of this study are to develop a validated analytical method to measure accurately and precisely the concentration of PH-189 in plasma and in the presence of other biological compounds and to indicate its stability by using a fast and reliable LC-MS instrumental technique available in our laboratory.
| Status | Finished |
|---|
| Effective start/end date | 1/12/16 → 30/11/17 |
|---|
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
-
SDG 3
Good Health and Well-being